{
    "xml": "<topic id=\"PHP2777\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/papaveretum\" basename=\"papaveretum\" title=\"PAPAVERETUM\">\n<title>PAPAVERETUM</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_100\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/papaveretum\">Papaveretum</xref>\n</p>\n<data name=\"vtmid\">354056002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_110392128\" title=\"Opioids\">Opioids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" title=\"OPIOIDS\" namespace=\"/drug-classes/opioids\">OPIOIDS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP56682\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/drugs/papaveretum\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Postoperative analgesia</p>\n<p outputclass=\"therapeuticIndication\">Severe chronic pain</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>7.7&#8211;15.4&#8239;mg every 4&#8239;hours if required.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 7.7&#8239;mg every 4&#8239;hours if required.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Premedication</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56739\" outputclass=\"importantSafetyInformation\" rev=\"1.17\" parent=\"/drugs/papaveretum\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Do <b>not</b> confuse with papaverine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56752\" outputclass=\"contraindications\" rev=\"1.6\" parent=\"/drugs/papaveretum\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Heart failure secondary to chronic lung disease</ph>; <ph outputclass=\"contraindication\">phaeochromocytoma</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56773\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/papaveretum\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Supraventricular tachycardia</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56606\" outputclass=\"sideEffects\" rev=\"1.9\" parent=\"/drugs/papaveretum\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypothermia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56789\" outputclass=\"breastFeeding\" parent=\"/drugs/papaveretum\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Therapeutic doses unlikely to affect infant.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56634\" outputclass=\"renalImpairment\" parent=\"/drugs/papaveretum\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57577\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.12\" parent=\"/drugs/papaveretum\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>The name <i>Omnopon</i>\n<tm tmtype=\"reg\"/> was formerly used for papaveretum preparations.</p>\n<p>Papaveretum is a mixture of 253 parts of morphine hydrochloride, 23 parts of papaverine hydrochloride and 20 parts of codeine hydrochloride.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56586\" outputclass=\"lessSuitableForPrescribing\" rev=\"1.10\" parent=\"/drugs/papaveretum\">\n<title>Less suitable for prescribing</title>\n<body>\n<section>\n<sectiondiv>\n<p>Papaveretum is less suitable for prescribing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2777-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/papaveretum\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: solution for injection</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76854\" title=\"Solution for injection\" namespace=\"/drugs/papaveretum/solution-for-injection\">Solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85615\" namespace=\"/drugs/hyoscine-hydrobromide-with-papaveretum\" title=\"HYOSCINE HYDROBROMIDE WITH PAPAVERETUM\" count=\"1\" rel=\"backlink\">HYOSCINE HYDROBROMIDE WITH PAPAVERETUM</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78520\" namespace=\"/treatment-summaries/analgesics\" title=\"Analgesics\" count=\"1\" rel=\"backlink\">Analgesics</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_100\" namespace=\"/interactions/list-of-drug-interactions/analgesics/opioid-analgesics/papaveretum\" title=\"Papaveretum\" count=\"1\" rel=\"link\">Papaveretum</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34573\" namespace=\"/drug-classes/opioids\" title=\"OPIOIDS\" count=\"1\" rel=\"link\">OPIOIDS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76854\" namespace=\"/drugs/papaveretum/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP2777",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/papaveretum",
    "basename": "papaveretum",
    "title": "PAPAVERETUM",
    "interactants": [
        {
            "id": "bnf_int_100",
            "label": "Papaveretum"
        }
    ],
    "vtmid": "354056002",
    "drugClassification": [
        "Opioids"
    ],
    "inheritsFromClass": [
        "OPIOIDS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Postoperative analgesia",
                        "html": "Postoperative analgesia"
                    },
                    {
                        "textContent": "Severe chronic pain",
                        "html": "Severe chronic pain"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "7.7&#8211;15.4 mg every 4 hours if required.",
                        "html": "<p>7.7&#8211;15.4&#8239;mg every 4&#8239;hours if required.</p>"
                    },
                    {
                        "textContent": "Initially 7.7 mg every 4 hours if required.",
                        "html": "<p>Initially 7.7&#8239;mg every 4&#8239;hours if required.</p>",
                        "ageGroup": "elderly"
                    },
                    {
                        "textContent": "Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.",
                        "html": "<p>Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Premedication",
                        "html": "Premedication"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.",
                        "html": "<p>Use 25 to 50% of the corresponding subcutaneous/intramuscular dose.</p>"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "Do not confuse with papaverine.",
                "html": "<p>Do <b>not</b> confuse with papaverine.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Heart failure secondary to chronic lung disease",
                "html": "Heart failure secondary to chronic lung disease"
            },
            {
                "type": "contraindications",
                "textContent": "phaeochromocytoma",
                "html": "phaeochromocytoma"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Supraventricular tachycardia",
                "html": "Supraventricular tachycardia"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hypothermia",
                        "html": "Hypothermia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Therapeutic doses unlikely to affect infant.",
                "html": "<p>Therapeutic doses unlikely to affect infant.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.",
                "html": "<p>Avoid use or reduce dose; opioid effects increased and prolonged and increased cerebral sensitivity occurs.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "The name Omnopon was formerly used for papaveretum preparations.\n\nPapaveretum is a mixture of 253 parts of morphine hydrochloride, 23 parts of papaverine hydrochloride and 20 parts of codeine hydrochloride.",
                "html": "<p>The name <i>Omnopon</i>\n<tm tmtype=\"reg\"/> was formerly used for papaveretum preparations.</p><p>Papaveretum is a mixture of 253 parts of morphine hydrochloride, 23 parts of papaverine hydrochloride and 20 parts of codeine hydrochloride.</p>"
            }
        ]
    },
    "lessSuitableForPrescribing": {
        "lessSuitableForPrescribing": [
            {
                "type": "lessSuitableForPrescribing",
                "textContent": "Papaveretum is less suitable for prescribing.",
                "html": "<p>Papaveretum is less suitable for prescribing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "solution for injection"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76854",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85615",
                "label": "HYOSCINE HYDROBROMIDE WITH PAPAVERETUM",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78520",
                "label": "Analgesics",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_100",
                "label": "Papaveretum",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34573",
                "label": "OPIOIDS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76854",
                "label": "Solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}